Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.

Saved in:
Bibliographic Details
Title: Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
Authors: Li, Lu1 (AUTHOR), Chen, Lu2 (AUTHOR), Yan, Lu2 (AUTHOR), Guo, Yueqian3 (AUTHOR), Li, Fang1 (AUTHOR), Fan, Ming1 (AUTHOR), Lan, Mei1 (AUTHOR), Lai, Xin1 (AUTHOR), Zhou, Jie1 (AUTHOR), Huang, Yecai1 (AUTHOR), Xu, Peng1 (AUTHOR), Lang, Jinyi1 (AUTHOR), Feng, Mei1,4 (AUTHOR) freda_fm@126.com
Source: Radiation Oncology. 7/4/2023, Vol. 18 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:1748717X
DOI:10.1186/s13014-023-02310-8